The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy

被引:177
作者
Shishido, S
Asanuma, H
Nakai, H
Mori, Y
Satoh, H
Kamimaki, I
Hataya, H
Ikeda, M
Honda, M
Hasegawa, A
机构
[1] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Pediat Urol & Kidney Transplantat, Tokyo 2048567, Japan
[2] Natl Saitama Hosp, Dept Clin Res, Div Pediat, Wako, Saitama, Japan
[3] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Nephrol, Tokyo, Japan
[4] Toho Univ, Sch Med, Dept Nephrol, Tokyo, Japan
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷 / 04期
关键词
D O I
10.1097/01.ASN.0000056189.02819.32
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic allograft nephropathy (CAN) is due to both immunologic and non-immunologic factors and results in the development of nonspecific pathologic features that may even be present in long-term well-functioning renal allografts. To investigate the natural history of CAN and potential risk factors associated with progression of these histologic lesions, this study evaluated the of histologic alterations of 124 sequential protocol biopsies performed at 2, 3, and 5 yr after transplantation in 46 patients who exhibited histologic evidence of CAN in the 1-yr biopsy. The occurrence of late acute rejection (AR) greater than 4 mo posttransplant was significantly associated with the development of histologic CAN. In contrast, early clinical AR occurring within 3 mo had no impact on the subsequent development of CAN at I yr. Subclinical AR was evident in association with CAN in 50%, 32%, 19%, and 16% of cases with CAN at 1, 2, 3, and 5 yr, respectively. These acute lesions correlated significantly with histologic progression defined as an increased CADI score of the follow-up biopsies. Furthermore, a group of patients who exhibited repeated subclinical AR in the sequential follow-up biopsies had a lower creatinine clearance at 5 yr after transplantation and worse long-term graft survival. In contrast, the absence of evidence of acute inflammation in association with CAN at any time point was associated with minimal deterioration in renal function or progression of renal lesions during the observation period. These results suggest that the persistence of chronic active inflammation may be responsible for the histologic progression of CAN.
引用
收藏
页码:1046 / 1052
页数:7
相关论文
共 24 条
[1]   RISK-FACTORS FOR CHRONIC REJECTION IN RENAL-ALLOGRAFT RECIPIENTS [J].
ALMOND, PS ;
MATAS, A ;
GILLINGHAM, K ;
DUNN, DL ;
PAYNE, WD ;
GORES, P ;
GRUESSNER, R ;
NAJARIAN, JS ;
FERGUSON ;
PAUL ;
SCHAFFER .
TRANSPLANTATION, 1993, 55 (04) :752-757
[2]   One-year routine renal transplant biopsies in children [J].
Benamenyo, JP ;
Droz, D ;
Niaudet, P .
PEDIATRIC NEPHROLOGY, 2001, 16 (12) :971-977
[3]  
ISONIEMI H, 1994, TRANSPLANTATION, V58, P1195, DOI 10.1097/00007890-199412150-00010
[4]   HISTOPATHOLOGICAL FINDINGS IN WELL-FUNCTIONING, LONG-TERM RENAL-ALLOGRAFTS [J].
ISONIEMI, HM ;
KROGERUS, L ;
VONWILLEBRAND, E ;
TASKINEN, E ;
AHONEN, J ;
HAYRY, P .
KIDNEY INTERNATIONAL, 1992, 41 (01) :155-160
[5]   HISTOPATHOLOGIC FINDINGS ASSOCIATED WITH A CHRONIC, PROGRESSIVE DECLINE IN RENAL-ALLOGRAFT FUNCTION [J].
KASISKE, BL ;
KALIL, RSN ;
LEE, HS ;
RAO, KV .
KIDNEY INTERNATIONAL, 1991, 40 (03) :514-524
[6]   Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients [J].
Legendre, C ;
Thervet, E ;
Skhiri, H ;
Mamzer-Bruneel, MF ;
Cantarovich, F ;
Noel, LH ;
Kreis, H .
TRANSPLANTATION, 1998, 65 (11) :1506-1509
[7]   Histological alterations in implant and one-year protocol biopsy specimens of renal allografts [J].
Lehtonen, SRK ;
Taskinen, EI ;
Isoniemi, HM .
TRANSPLANTATION, 2001, 72 (06) :1138-1144
[8]   Immune-activation gene expression in clinically stable renal allograft biopsies - Molecular evidence for subclinical rejection [J].
Lipman, ML ;
Shen, YN ;
Jeffery, JR ;
Gough, J ;
McKenna, RM ;
Grimm, PC ;
Rush, DN .
TRANSPLANTATION, 1998, 66 (12) :1673-1681
[9]  
Matas A J, 2000, Pediatr Transplant, V4, P92, DOI 10.1034/j.1399-3046.2000.00096.x
[10]  
Motoyama O, 1997, Pediatr Transplant, V1, P29